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Abstract
We have recently described an acyl-CoA thioesterase specific for very-long-chain fatty acids, named ARTISt, that
regulates steroidogenesis through the release of arachidonic acid in adrenal zona fasciculata cells. In this paper we
demonstrate the presence of the protein as a 43 kDa band and its mRNA in cardiac tissue. The activity of the protein was
measured using an heterologous cell-free assay in which it is recombined with adrenal microsomes and mitochondria to
activate mitochondrial steroidogenesis. Isoproterenol and phenylephrine activate the enzyme in a dose-dependent manner
(10310^1036 M). Both propranolol (1035 M) and prazosin (1035 M) block the action of isoproterenol and phenylephrine
respectively. Antipeptide antibodies against the serine lipase motif of the protein and the Cys residue present in the catalytic
domain also block the activity of the protein. Taken together, our results confirm the presence of ARTISt in heart and
provide evidence for a catecholamine-activated regulatory pathway of the enzyme in that tissue. ß 1999 Elsevier Science
B.V. All rights reserved.
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1. Introduction
Arachidonic acid (AA) and its eicosanoic metabo-
lites (e.g. prostaglandins, leukotrienes and epoxides)
play critical roles in the initiation or modulation of a
broad spectrum of physiological responses and cer-
tain abnormal processes in mammalian cells [1^3].
AA is not freely stored in the cells, instead, it is
esteri¢ed to cellular phospholipids mainly at the
sn-2 position [4]. A number of di¡erent pathways for
the mobilization of AA have been proposed, includ-
ing phospholipase C in concert with glycerol lipases,
lysophospholipase and phospholipase A2.
Recently, a novel mechanism for the release of AA
has been proposed. This mechanism involves the re-
lease of AA by hydrolysis of the thioester linkage of
the fatty acid to CoA [5] by a thioesterase with sub-
strate speci¢city for very-long-chain fatty acids [6].
The ¢rst demonstration of such mechanism was ob-
tained by studying peptide hormone regulation of
steroid synthesis. We have isolated [7], cloned and
sequenced [5] a protein that plays an obligatory
role in the activation of steroidogenesis, through
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the release of AA, from adrenal zona fasciculata
cells. The protein has been characterized as a thio-
esterase using arachidonoyl-CoA as substrate and
named arachidonic acid-related thioesterase involved
in steroidogenesis (ARTISt) [5]. The activity of the
protein is controlled by a hormone-regulated protein
phosphorylation mechanism, which may then consti-
tute an alternative regulatory mechanism for the re-
lease of AA.
A similar very-long-chain acyl-CoA thioesterase
has been isolated and sequenced from liver [8]. This
enzyme is located in liver mitochondria and can be
induced by peroxisome proliferators.
ARTISt messenger is expressed in steroidogenic as
well as in non-steroidogenic tissues such as kidney,
liver and heart [8,9], indicating that the protein could
actually consist of a family of proteins related to the
regulation of fatty acid release acting in di¡erent
tissues.
The e¡ects of AA and its metabolites in cardiac
tissue are various and profound. Recent studies in-
dicate that the release of AA in response to physio-
logical agonists may be an important paracrine sig-
naling event in heart, leading to alterations in cardiac
contractility [10]. AA also causes the uncoupling of
cells by closing gap junction channels [11] and it was
demonstrated to induce changes in the inotropic state
of isolated perfused heart [12]. In its turn, stimula-
tion of AA release by adrenoceptors has been dem-
onstrated in a variety of cells [13] and it has been
suggested that release of AA in response to receptor
activation by endogenous mediators or pathological
stimuli may be involved in mediating inotropic
response in cardiac muscle [14,15]. In addition,
heart muscle is one of the tissues in which lipoxyge-
nase products have been shown to exert a pathophy-
siological prominence with the onset of ischemia
[16,17].
Given the presence of ARTISt in heart and the
involvement of AA in the regulation of cardiac func-
tion, we investigate whether ARTISt can be regu-
lated in isolated perfused hearts by catecholamines.
The model used for this study includes a heterolo-
gous recombination assay, where adrenal mitochon-
dria are challenged by ARTISt isolated from cate-
cholamine-stimulated hearts.
2. Materials and methods
2.1. Materials
9-Fluoro-11L,17,21-trihydroxy-16K-methylpregna-
1,4-diene-3,20-dione (dexamethasone) and the inhib-
itors 2-methyl-1,2-di-3-pyridyl-1-propanone (Meto-
pyrone, 21-hydroxylase inhibitor) and 1-(L-guanidi-
noethyl)-3-(4-pyridyl)indol sulfate (Ba 40.028, 11L-,
18- and 19-hydroxylase inhibitor) were a kind gift
from Ciba Geigy (Basel, Switzerland). Isoproterenol
(ISOP), phenylephrine (PHE), propranolol (PROP),
prazosin (PRAZ), nordihydroguayaretic acid
(NDGA), protein kinase A inhibitor (PKI), alkaline
phosphatase-conjugated goat anti-rabbit immunoglo-
bulin G, 5-bromochloro-3-indolylphosphate, nitro-
blue tetrazolium and Ponceau S were purchased
from Sigma (St. Louis, MO, USA). All other re-
agents were commercial products of the highest
grade available.
2.2. Animals
Adult Wistar rats (200^300 g) were used through-
out. For heart perfusion experiments, rats were
fasted overnight but given ad libitum access to water.
For adrenal preparations, rats had free access to
both rat chow and water, and were supplied with
dexamethasone (10 Wg/ml, ad libitum) in the drinking
water 16 h before sacri¢ce.
2.3. Heart perfusion
Animals were anesthetized with ether and received
heparin. The thorax was opened, and the heart re-
moved and placed in Krebs-Henseleit bu¡er (KHB)
containing the following components: 114 mM
NaCl, 1.2 mM KH2PO4, 2.5 mM CaCl2, 1.2 mM
MgSO4, 4.7 mM KCl, 25 mM NaHCO3 and 5.5
mM glucose, equilibrated with 95% oxygen-5% CO2.
Hearts were perfused via the aorta according to
the method of Langendor¡, using a universal organ
perfusion system (Harvard Apparatus, Millis, MA,
USA). The hearts were perfused at a constant rate
of 8 ml/min with KHB using a peristaltic pump
(Harvard Apparatus). The water jacket surrounding
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the organ was warmed to 37‡C by a heater pump
(Techne, Cambridge, UK). After equilibration the
hearts were perfused during 15 min with 1036^
10310 M of either ISOP or PHE, and with 1035 M
PROP or PRAZ prior to 1037 M ISOP or PHE
perfusion respectively. Control hearts were perfused
only with KHB.
2.4. Preparation of cardiac cytosol
After perfusion, the hearts were chopped with scis-
sors and washed with ice cold bu¡er A (270 mM
mannitol, 10 mM Tris-HCl bu¡er, pH 7.4) to remove
all of the blood. Next, the hearts were transferred to
a Te£on, motorized Ultraturrax homogenizer and
homogenized in 5 ml of bu¡er A per gram of
chopped heart. The homogenate was centrifuged at
800Ug for 10 min. The supernatant was centrifuged
at 9000Ug for 20 min. The supernatant was centri-
fuged at 105 000Ug for 60 min to obtain the cytosol
and the microsomal fraction.
2.5. Preparation of adrenal mitochondrial and
microsomal fractions
Animals were sacri¢ced by decapitation and adre-
nal glands were excised and kept on ice. Adrenal
mitochondrial and microsomal fractions were ob-
tained as described elsewhere [18]. Brie£y, adrenal
zona fasciculata tissue from dexamethasone-treated
rats was homogenized in 0.2 ml of bu¡er A per adre-
nal gland. The homogenate was centrifuged at
800Ug for 10 min. The mitochondrial fraction was
obtained by centrifugation of the 800Ug supernatant
at 9000Ug for 20 min. The obtained pellet was
rinsed with bu¡er A, then resuspended in 0.2 ml of
fresh bu¡er A/adrenal gland. The 9000Ug superna-
tant was centrifuged at 105 000Ug for 60 min to
obtain the 105 000Ug pellet (microsomal fraction)
and the cytosol. The pellet was rinsed with bu¡er
A and resuspended in 0.1 ml/adrenal gland of bu¡er
A.
2.6. In vitro heterologous recombination assay
An in vitro modi¢ed recombination assay was per-
formed as described elsewhere [18]. Brie£y, cardiac
cytosol (0.10 ml) and adrenal microsomal fraction
(0.05 ml) were recombined with 0.10 ml of the adre-
nal mitochondrial fraction in a ¢nal volume of 0.7 ml
in the presence of 0.27 mM Metopyrone and 1.6 mM
Ba 40.028 as inhibitors of progesterone and pregne-
nolone metabolism. The mixture was incubated for
10 min at 37‡C and stopped by cooling the tubes on
ice/water and by addition of 2 ml cold methanol/2.5
mM HCl (1:1, v/v)/tube. Steroids were extracted and
progesterone production determined by radioimmu-
noassay (RIA). The RIA for pregnenolone was con-
sidered less speci¢c than that for progesterone since a
cross-reaction with lipophilic pregnenolone esters
present in adrenal tissue could not be excluded.
Therefore, the determination of progesterone was
chosen as the main measurement of side chain cleav-
age [18] and expressed as pg of progesterone per
incubation.
2.7. Incubation with ARTISt antibodies
Cytosol of ISOP 1037 M perfused heart was incu-
bated overnight with ARTISt antipeptide antibodies
[7] or rabbit normal serum (NS) at 4‡C. The ability
of the antibody incubated cytosols to activate pro-
gesterone synthesis in the presence of unstimulated
adrenal mitochondria and microsomes was meas-
ured.
2.8. Western blot analysis
For Western blot analysis [19], cardiac cytosol (10
Wg protein) was loaded and resolved on a 5^17%
gradient SDS-polyacrylamide gel under non-reducing
conditions. Proteins were electrophoretically trans-
ferred to nitrocellulose membranes using 25 mM
Tris, 192 mM glycine, pH 8.3, containing 20% meth-
anol. The transfer was performed at a constant volt-
age of 6 V for 150 min. Protein transfer was moni-
tored by staining of the nitrocellulose membrane
with Ponceau S. Membranes were then incubated
with 5% fat-free powdered milk in NaCl/Pi (2.7
mM KCl, 140 mM NaCl, 10 mM Na2HPO4, pH
7.4), 0.5% Tween 20 for 30 min at room temperature
with gentle shaking, rinsed twice in NaCl/Pi, Tween
20 and incubated overnight with appropriate dilu-
tions of antibody at 4‡C. Bound antibodies were de-
tected using alkaline phosphatase-conjugated goat
anti-rabbit immunoglobulin G with 5-bromochloro-
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3-indolylphosphate and nitroblue tetrazolium as sub-
strate.
2.9. Northern blot analysis
Total RNA from cardiac tissue was extracted by
the method of Chomczynski [20] and quanti¢ed spec-
trophotometrically at 260 nm. RNA samples (24 Wg)
were denatured at 65‡C for 15 min in 45% form-
amide/5.4% formaldehyde and electrophoresed at
room temperature on a 1.2% agarose/2.2 M formal-
dehyde gel. RNA was transferred by capillarity to
nylon membranes in 20USSC (1USSC: 150 mM
NaCl, 15 mM sodium citrate) and ¢xed by baking
of the membranes for 2 h at 80‡C. Blots were prehy-
bridized for 4^5 h at 42‡C in 10 ml of 50% form-
amide, 1% SDS, 1UDenhardt’s reagent, 5USSC and
100 Wg/ml of denatured salmon sperm DNA. Hybrid-
ization was performed overnight at 42‡C as previ-
ously described [5]. They were then subjected to
autoradiography using intensifying screens for 18^
72 h at 380‡C.
2.10. Protein determination
Protein concentration was determined by the
method described by Lowry [21] using bovine serum
albumin as standard.
2.11. Data analysis
Results are shown as the mean þ S.E.M. Statistical
signi¢cance was evaluated using ANOVA followed
by Tukey’s test; P6 0.05 was considered signi¢cant.
3. Results
3.1. Detection of ARTISt and its mRNA in cardiac
tissue
The presence of ARTISt mRNA was detected in
heart, as two transcripts, by Northern blotting using
a 795 bp PCR ampli¢cation product as a probe (Fig.
1A).
ARTISt was found in cardiac cytosol, using di¡er-
ent antibodies against several peptides of the protein.
All tested antibodies speci¢cally detected the protein
as a 43 kDa band as shown for adrenal ARTISt [7].
Shown in Fig. 1B is the band obtained using an
antipeptide antibody raised against the lipase serine
motif.
3.2. E¡ect of ISOP on the stimulation of acyl-CoA
thioesterase activity (ARTISt)
The activity of cardiac ARTISt was analyzed using
a heterologous recombination assay as described in
Section 2.
In this assay, the protein from adrenal gland was
demonstrated to induce AA release that after further
metabolism to leukotrienes will stimulate steroid syn-
thesis in unstimulated adrenal mitochondria. In ad-
dition the e¡ect of the protein is blocked by the
addition of inhibitors of AA such as NDGA (a lip-
oxygenase pathway inhibitor) [7,22,23].
ISOP (10310^1036 M) produced a dose-dependent
increase of cardiac ARTISt activity measured as the
capacity of the protein to stimulate steroid synthesis
(Fig. 2). The e¡ect became signi¢cant above 1038 M.
ISOP e¡ect was blocked by addition of PROP. These
results suggest that ISOP-stimulated heart could ac-
tivate ARTISt activity via a L-adrenoceptor-associ-
ated mechanism.
Fig. 1. Northern and Western blots of ARTISt in cardiac tis-
sue. (A) RNA (24 Wg) from cardiac and adrenal tissues was
electrophoresed and transferred to nylon membranes. A 795 bp
PCR product from a 1.4 kb fragment was used as a probe as
described elsewhere [5]. They were then subjected to autoradiog-
raphy using intensifying screens for 18^72 h at 380‡C. (B) My-
ocardial and adrenal cytosol (10 Wg) were electrophoresed, elec-
trotransferred to nitrocellulose membranes and probed using an
antipeptide antibody (G11K) directed against the lipase serine
motif of ARTISt.
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3.3. E¡ect of NDGA
In order to study whether the activity of ARTISt
from cardiac tissue is also a¡ected by inhibition of
AA metabolism, the adrenal microsomal fraction
was preincubated with 5 WM NDGA, during 30
min at 37‡C prior to the heterologous recombina-
tion. As expected, preincubation of the microsomal
fraction with NDGA resulted in a signi¢cant inhib-
ition of progesterone synthesis (Fig. 3). Moreover,
the increase in progesterone synthesis is observed
only in the presence of adrenal microsomes, the
source of the lipoxygenase enzyme.
3.4. E¡ect of ARTISt antipeptide antibodies
To con¢rm that the activity of cardiac cytosol was
due to the presence of activated ARTISt, we studied
the e¡ect of speci¢c antipeptide antibodies on en-
zyme activity. The activity of cardiac cytosol was
blocked by addition of antibodies against the N-ter-
minal sequence of ARTISt (FG7), and against inter-
nal peptides of the protein (FR7, G11K and A10A).
The activity was una¡ected by addition of normal
rabbit serum and of the antipeptide antibody V15Q
(Fig. 4).
3.5. E¡ect of protein kinase A inhibitor
In order to exclude that the e¡ect of ISOP is due
to the addition of activated cAMP-dependent protein
kinase (PKA) present in the cytosol, the heterologous
in vitro recombination assay was performed in the
presence of a PKA inhibitor (PKI). As shown in
Table 1, addition of the inhibitor had no e¡ect on
the activity of ARTISt measured as the capacity of
the protein to stimulate progesterone synthesis.
3.6. E¡ect of PHE on the stimulation of acyl-CoA
thioesterase activity (ARTISt)
As for ISOP, PHE (10310^1036 M) produced a
dose-dependent increase of ARTISt activity meas-
ured as the capacity of the protein to stimulate ste-
roid synthesis (Fig. 5). Again, the e¡ect became sig-
ni¢cant at concentrations above 1038 M.
PHE e¡ect was blocked by addition of 1035 M
PRAZ suggesting the involvement of an K-adreno-
Fig. 3. E¡ect of NDGA. Adrenal microsomes were preincu-
bated for 30 min at 37‡C with NDGA 5 WM or bu¡er only.
Cytosol from ISOP and KHB perfused heart was recombined
with or without the preincubated microsomes and adrenal mito-
chondria in a heterologous recombination assay and progester-
one production was measured. Data are shown as the mean þ
S.E.M., n = 4. *Signi¢cantly di¡erent from control values
(P6 0.05). Results shown are representative of three independ-
ent experiments.
Fig. 2. E¡ect of ISOP and PROP. Hearts were perfused for 15
min with di¡erent concentrations of ISOP (a) or with the L-
adrenoceptor antagonist PROP (1035 M) and then for another
15 min with 1037 M ISOP (8). Cytosols from perfused hearts
were recombined with adrenal mitochondria and microsomes in
an in vitro recombination assay. Progesterone was extracted
from the assay medium with 1.5 ml of cyclohexane and its con-
tent was determined by RIA. Data are shown as the mean þ
S.E.M., n = 4. **Signi¢cantly di¡erent (P6 0.01) from basal val-
ues; signi¢cantly di¡erent (P6 0.01) from 1037 M ISOP. Re-
sults shown are representative of ¢ve independent experiments.
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ceptor-associated mechanism in the activation of
ARTISt.
4. Discussion
Our results show that an acyl-CoA thioesterase
speci¢c for very-long-chain fatty acids and its
mRNA are expressed in cardiac tissue. We also dem-
onstrate that the activity of this protein, named AR-
TISt, can be regulated by ISOP and PHE in a mech-
anism that involves both L- and K-adrenoceptors.
We have previously shown that the function of
ARTISt in steroidogenic tissues was determined us-
ing an in vitro recombination cell-free assay [18].
Using that assay, the protein was demonstrated to
induce AA release that after further metabolism to
leukotrienes will stimulate steroid synthesis in unsti-
mulated adrenal mitochondria. The activity of AR-
TISt from cardiac tissue was studied here by means
of a similar recombination cell-free assay using the
cytosol of cardiac tissue as a source of protein. Using
this assay we demonstrate that ISOP could regulate
ARTISt activity. Our results show that the activity of
cardiac cytosol was due to the presence of active
ARTISt since speci¢c antipeptide antibodies against
the protein completely abolished the activity present
in cytosols isolated from ISOP-perfused hearts.
We are con¢dent of the speci¢city of the e¡ect of
ISOP described in this study since the e¡ect was
dose-dependent, in a concentration range known to
exert physiological responses and blocked by speci¢c
L-adrenoceptor antagonists. ARTISt from hearts
perfused in the absence of ISOP produced no e¡ect.
Fig. 5. E¡ect of PHE and PRAZ. Hearts were perfused with
di¡erent concentrations of PHE (a) or with the K-adrenoceptor
antagonist PRAZ (1035 M) and then for another 15 min with
1037 M PHE (8). Cytosols from perfused hearts were recom-
bined with adrenal mitochondria and microsomes in an in vitro
recombination assay. Net progesterone production in adrenal
mitochondria was determined by RIA. Data are shown as the
mean þ S.E.M., n = 4. **Signi¢cantly di¡erent from controls
(P6 0.01); signi¢cantly di¡erent from 1037 M PHE
(P6 0.01). Results shown are representative of three independ-
ent experiments.
Table 1
E¡ect of protein kinase A inhibitor
Cytosol PKI Progesterone (pg/inc.)
Control 3 NDa
+ ND
ISOP 3 810 þ 60
+ 780 þ 30
Cytosols obtained from control and ISOP (1037 M)-perfused
hearts were preincubated either with PKI (100 Wg/ml) or bu¡er
only, and recombined with adrenal microsomal and mitochon-
drial fractions
Progesterone production was determined as previously de-
scribed.
aND, not detectable.
Fig. 4. Incubation of the ISOP-stimulated cytosol with ARTISt
antipeptide antibodies. Rat hearts were perfused with 1037 M
ISOP for 15 min. Cytosols from perfused hearts were obtained.
Aliquots of 100 Wl (400 Wg of protein) of cytosol were incu-
bated overnight with di¡erent ARTISt antipeptide antibodies
(1:100) and with rabbit normal serum (NS) (1:100) at 4‡C.
After incubation cytosols were recombined with adrenal mito-
chondria and microsomes and net progesterone synthesis was
measured by RIA. Data are shown as the mean þ S.E.M., n = 4.
*Signi¢cantly di¡erent from NS values (P6 0.05). Results
shown are representative of three independent experiments.
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It is known that ARTISt is regulated by PKA in
LH-stimulated Leydig cells and in ACTH-stimulated
adrenal zona fasciculata cells [22,24]. Since ISOP in-
creases PKA activity [25] a possible e¡ect of acti-
vated PKA generated after L-adrenergic agonism
was ruled out on the basis of the results obtained
with PKI.
We cannot conclude from our results that ARTISt
in cardiac tissue will follow the same mechanism of
action as in steroidogenic tissue, e.g. AA release.
However, we conclude that ISOP is able to stimulate
the acyl-CoA thioesterase activity. This is supported
by: (a) antibodies against the lipase serine motif of
ARTISt (G11K) and against the Cys residue present
in the catalytic domain block the activity of the car-
diac protein as has been reported for LH and ACTH
[5,9] ; (b) the e¡ect of ARTISt from cardiac tissue is
blocked by NDGA as was demonstrated in adrenal
tissue. Further support comes from the observation
that ARTISt from cardiac tissue releases AA from
arachidonoyl-CoA in vitro in an ISOP-regulated
manner (manuscript in preparation).
Taken together, our results will suggest that the
acyl-CoA thioesterase will release AA or another
fatty acid that will act as a signal transducer in re-
sponse to adrenergic agonism in cardiac tissue. The
question as to how fatty acids esteri¢ed to CoA are
produced and stored in cardiac tissue to serve as
substrate for this enzyme is a topic that still remains
to be elucidated.
There are several types of acyl-CoA synthetase
(ACS) that are expressed to various degrees in di¡er-
ent tissues. ACS1 is the well characterized ACS
abundant in liver, adipose tissue and heart and ex-
hibits a broad fatty acid speci¢city [26^28]. A novel
arachidonate-preferring synthetase (ACS4) is present
in steroidogenic cells of rat adrenal, ovary and testis
[29]. This protein, although at low amounts, is also
expressed in heart [29]. Interestingly, in tissues where
ARTISt is expressed, such as steroidogenic tissues,
liver, kidney, heart and brain, an acyl-CoA synthe-
tase is found that is able to catalyze the activation of
very-long-chain fatty acids to produce acyl-CoA. It
may then be possible for ARTISt to release AA or
another fatty acid in cardiac tissue to serve as a
signal transduction mechanism as it does in steroido-
genic cells.
The results presented in this paper constitute the
¢rst evidence indicating that catecholamines could
regulate the activity of a thioesterase speci¢c for
very-long-chain acyl-CoA.
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